Advertisement

Neurovirulence for Mice of Soluble Receptor-Resistant Mutants of Murine Coronavirus JHMV

  • Shutoku Matsuyama
  • Rihito Watanabe
  • Fumihiro Taguchi
Chapter
  • 44 Downloads
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 494)

Abstract

Soluble receptor-resistant (srr) mutants isolated from a highly neurotropic mouse hepatitis virus (MHV), JHMV cl-2 strain, have a single mutation in either SI or S2 subunit of spike (S) protein (Saeki et al., 1997). These mutants were shown to grow and induce syncytia in cultured cells as efficiently as wild type (wt) virus (Saeki et al., 1997). Since it has been reported that the S protein is a key determinant in the viral virulence for animals (Dalziel et al., 1986; Fleming et al., 1986; Philips et al., 1999), we have attempted to see whether the mutations observed in srr mutants affect the neurovirulence of JHMV.

Keywords

Mouse Hepatitis Virus Spike Protein Central Nervous System Symptom Murine Hepatitis Virus Single Amino Acid Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Dalzie, R-G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J.Virol. 59:463–471.Google Scholar
  2. Fleming, J. O., M. D. Trousdale, F. A. K. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine Coronavirus JHM selected with monoclonal antibodies. J.Virol. 58:869–875.PubMedGoogle Scholar
  3. Phillips, J. J., M. M. Chua, E. Lavi and S. R. Weiss. 1999. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine Coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 73:7752–7760PubMedGoogle Scholar
  4. Saeki, K., N. Ohtsuka, and F. Taguchi. 1997. Identification of spike protein residues of murine Coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol. 71:9024–9031PubMedGoogle Scholar
  5. Taguchi, F., S. G., Siddell, H. Wege, and V.ter Meulen. 1985. Characterization of a variant virus selected in rat brain after infection by Coronavirus mouse hepatitis virus JHM. J. Virol. 54:429–435.PubMedGoogle Scholar
  6. Taguchi, F., A. Yamada, and K. Fujiwara. 1980. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages. Infect. Immun. 29:42–49.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Shutoku Matsuyama
    • 1
  • Rihito Watanabe
    • 2
  • Fumihiro Taguchi
    • 1
  1. 1.National Institute of Neuroscience NCNPKodaira TokyoJapan
  2. 2.Institute of Life ScienceSoka UniversityTokyoJapan

Personalised recommendations